SPRO- Spero Therapeutics, Inc.

Name: Spero Therapeutics, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Spero Therapeutics, Inc. (SPRO) has 10 insiders with recent SEC Form 4 filings, including 0 buys and 14 sells. SPRO is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
Other	Rajavelu Esther	986.9K	$2.53M	-25,240
COO	Keutzer Timothy	742.5K	$1.90M	-
Dir	Mahadevia Ankit	703.3K	$1.80M	-
Dir	Deshpande Milind	91.5K	$234.1K	-
Dir	Tregoning Kathleen	75.0K	$192.0K	-

Activity

Buys and sells only

Transactions

10 filings

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
May 4, 2026	Rajavelu Esther	See Remarks	Sell	25,240	$2.51	$63,352.40	-2.5%	-	-
Feb 6, 2026	Rajavelu Esther	See Remarks	Sell	87,917	$2.36	$207,484.12	-4.1%	-	-
Feb 6, 2026	Keutzer Timothy50	Chief Operating Officer	Sell	18,652	$2.36	$44,018.72	-2.5%	-	-
Feb 4, 2026	Keutzer Timothy50	Chief Operating Officer	Sell	46,586	$2.17	$101,174.60	-2.0%	+8.3%	-
Feb 2, 2026	Rajavelu Esther	See Remarks	Sell	18,442	$2.20	$40,572.40	-1.6%	+11.2%	-
Nov 7, 2025	Rajavelu Esther	See Remarks	Sell	40,270	$2.37	$95,439.90	-4.4%	-6.5%	-
Aug 28, 2025	Mahadevia Ankit58	Director	Sell	6,572	$1.97	$12,946.84	-0.9%	+16.5%	-
Aug 28, 2025	Keutzer Timothy50	Chief Operating Officer	Sell	1,695	$1.97	$3,339.15	-0.2%	+16.5%	-
Feb 5, 2025	Mahadevia Ankit58	Director	Sell	69,219	$0.78	$53,990.82	-4.6%	-32.7%	+162.3%
Feb 5, 2025	Rajavelu Esther	CFO &Cbo	Sell	20,689	$0.78	$16,137.42	-2.8%	-32.7%	+162.3%

Page 1Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC